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Aims: Cardiorespiratory fitness is an important predictor of cardiovascular morbidity and
mortality. Both red cell distribution width (RDW) and inflammatory markers like C-reactive
protein (CRP) have been shown to predict adverse outcomes in patients with heart disease.
Methods: We utilized pooled data from NHANES 1999e2004 to assess cardiorespiratory
fitness in healthy adults 12e49 years old using submaximal exercise. The primary outcome
was the estimated maximal oxygen uptake (VO2max). Low fitness was defined as
VO2max < 20th percentile of age- and gender-based reference category.
Results: In our study, we estimated 21.2% of individuals had low fitness. Elevated RDW
(>13%) was encountered in 20.4% subjects with low fitness as compared to 14.0% subjects
in the control group ( p < 0.001). Similarly, elevated CRP (>0.5 mg/dL) was found among
17.4% subjects with low fitness as compared to 12.4% subjects in the control group
( p < 0.001). Adjusted analysis demonstrated a doseeresponse relationship between low
cardiorespiratory fitness and increasing RDW or CRP.
Conclusion: In a large representative database of general US population, we observed
a significant association between elevated RDW and elevated CRP with low cardiorespi-
ratory fitness.
Copyright ª 2012, Cardiological Society of India. All rights reserved.1. Introduction cardiovascular disease at baseline, after adjustment forAlthough there has been a substantial decline in themortality
attributed to cardiovascular disease over the last three
decades, it remains the leading cause of death in the United
States.1 Several large studies have demonstrated a consistent,
inverse relationship between cardiorespiratory fitness
measured using exercise capacity and cardiovascular disease
outcomes, including long-term mortality.2e5 This association
has been demonstrated in subjects with or without0.
il.com.
2012, Cardiological Societraditional cardiovascular risk factors.5 Among subjects with
prevalent risk factors including hypercholesterolemia,
hypertension, diabetes or active smoking, the presence of
high exercise capacity in midlife was found to substantially
reduce the risk of long-termmorbidity due to presence of risk
factors.3
Several hypotheses have been generated regarding
pathophysiologic mechanisms preceding the genesis of
cardiovascular disease. Chronic subclinical inflammation isty of India. All rights reserved.
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adverse cardiovascular events.6e8 In addition, high oxidative
stress has been shown to be a potential contributing mecha-
nism in the pathogenesis of cardiovascular disease.9 Red cell
distribution width (RDW) is a recently described novel
biomarker that has been shown to be predictive of adverse
outcomes in multiple cardiovascular disease settings
including stable coronary artery disease, chronic heart failure
and acute myocardial infarction.10e13 Although the plausible
pathobiological mechanisms explaining the relationship of
RDW with adverse cardiovascular outcomes are yet to be
elucidated, both inflammation and oxidative stress are
believed to play a role.7,14
Although there is ample evidence to suggest that low
exercise capacity predicts adverse cardiovascular outcomes,
the evidence surrounding the determinants of low exercise
capacity are rather scarce. We aimed to study the associa-
tion between RDW, inflammatory markers and low exercise
capacity using a large national database of the non-
institutionalized population representative of the general
US population.2. Methods
2.1. Study population
This study analyzed pooled National Health and Nutrition
Examination Survey (NHANES) data from 1999e2000,
2001e2002 and 2003e2004.15 NHANES is an ongoing cross-
sectional survey of the civilian, non-institutionalized US
population that provides a representative sample for calcu-
lation estimates of national health and nutritional status.
Survey participants aged 12e49 years without physical limi-
tations or pre-existing cardiovascular or pulmonary diseases
were eligible for cardiorespiratory fitness testing.
2.2. Estimation of exercise capacity
Cardiorespiratory fitness was measured using submaximal
exercise testing. Based on the subject’s age, body mass indexTable 1 e Determination of exercise protocol based on predicte
and physical activity score. Based on the predicted VO2max, e
a pre-determined speed (measured inmiles per hour) and grade
the test was chosen such that the activity level would correspo
and 75% of predicted VO2max in the warm-up phase, stage 1
Predicted VO2max
(mL/kg/min)
Exercise
protocol
number
Warm-up
Speed
(mph)
Grade
(%)
Spe
(mp
<20 1 1.7 0 2.
20e24 2 2.0 1.0 2.
25e29 3 2.2 2.0 2.
30e34 4 2.7 2.0 3.
35e39 5 3.0 3.0 3.
40e44 6 3.1 3.5 3.
45e49 7 3.2 5.0 3.
50 8 3.6 5.0 3.(BMI), gender and self-reported level of physical activity, the
system calculated the predicted maximal oxygen consump-
tion (predicted VO2max) for each participant. Subsequently,
each participant was assigned to one of eight standardized
treadmill protocols based on the predicted VO2max [Table 1].
The goal of each protocol was to elicit a heart rate>75% of age
predicted maximum heart rate (220-age) by test termination.
Each protocol included a 2-min warm-up, two 3-min exercise
stages and a 2-min cool-down period.
Heart rate was continuously monitored using four elec-
trodes connected to the subject’s chest and abdomen. Blood
pressure was measured at the end of warm-up, each exercise
stage and each minute of the cool-down period. Each partici-
pant was asked to rate the level of exertion at the end of
warm-up and both exercise stages using a Borg scale. This was
termed Rating of Perceived Exertion (RPE).
The primary outcome of exercise testing was the deter-
mination of estimated maximal oxygen uptake (estimated
VO2max). Since the relationship between heart rate and
oxygen consumption is linear during exercise, it is possible to
estimate the VO2max bymeasuring the heart rate response to
known levels of submaximal work.
The level of cardiorespiratory fitness was categorized low,
moderate and high fitness based on age- and gender-specific
cut-points of estimated VO2max. The reference cut-points
that were utilized for adults 20e49 years of age were based
on the data from the Aerobics Center Longitudinal Study
(ACLS).16,17 Low-fitness level was defined as estimated
VO2max below the 20th percentile for the same gender and
age group. Moderate fitness level was defined as a value
between the 20th and 59th percentile and high fitness level
was defined as a value above the 60th percentile of the
respective age and gender group. The reference standards
utilized for the adolescents and young adults 12e19 years
were based on the criteria used in the FITNESSGRAM
program.18,19
2.3. Measurement of RDW and inflammatory markers
We utilized C-reactive protein (CRP) as the surrogate marker
for overall body inflammation in our study and measuredd VO2max calculated using age, gender, body mass index
ach participant was assigned to an exercise protocol with
(percent incline). The speed and the grade for each stage of
nd to 45% of predicted VO2max, 55% of predicted VO2max
and stage 2 of the testing protocol respectively.
Stage 1 Stage 2 Recovery
ed
h)
Grade
(%)
Speed
(mph)
Grade
(%)
Speed
(mph)
Grade
(%)
1 0.5 2.1 4.5 2.0 0
3 2.0 2.3 6.5 2.0 0
7 3.0 2.7 7.5 2.0 0
1 4.0 3.1 8.5 2.0 0
7 4.0 3.7 8.0 2.0 0
7 5.5 3.7 10.0 2.0 0
7 7.0 3.7 12.5 2.0 0
7 8.5 3.7 14.5 2.0 0
Table 2 e Baseline characteristics.
Low fitness
(n ¼ 2394)
Controls
(n ¼ 5930)
p-Value
Prevalence 21.2 (0.9) 78.8 (0.9)
Males 48.3 (1.4) 53.2 (1.1) <0.001
Females 51.7 (1.4) 46.8 (1.1) <0.001
Mean (SE) age (years) 24.5 (0.4) 30.0 (0.2) <0.001
Race
Whites 60.7 (2.9) 70.2 (1.4) <0.001
Blacks 15.7 (1.7) 10.6 (0.9) <0.001
Mexican-Americans 11.9 (1.7) 9.5 (0.9) 0.006
Others 11.7 (1.6) 9.6 (1.0) 0.06
Co-morbidities
Hypertension 5.8 (1.0) 5.9 (0.4) 0.9
Hyperlipidemia 8.7 (1.1) 10.3 (0.5) 0.2
Diabetes 1.5 (0.5) 0.9 (0.2) 0.2
Mean (SE) BMI (kg/m2) 27.3 (0.2) 25.6 (0.1) <0.001
BMI categories
<25 kg/m2 41.5 (1.7) 53.0 (1.1) <0.001
25e30 kg/m2 28.5 (13.6) 28.3 (1.0) 0.9
30 kg/m2 30.0 (1.5) 18.8 (0.8) <0.001
Chronic Kidney Disease
(GFR < 60 mL/
min/1.73 m2)
0.4 (0.2) 1.1 (0.3) 0.09
Smoking status
Never-smoker 50.3 (2.9) 50.6 (1.5) 0.9
Mean (SE) serum cotinine 0.36 (0.07) 0.27 (0.02) 0.2
Former-smoker 13.1 (1.8) 14.2 (0.8) 0.3
Mean (SE) serum cotinine 0.36 (0.1) 0.38 (0.05) 0.6
Active-smoker 36.5 (2.4) 35.2 (1.3) 0.4
Mean (SE) serum cotinine 175.1 (8.5) 178.3 (5.3) 0.6
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nephelometry with results reported within the range of
0.01e20 mg/dL. Elevated CRP was defined as CRP concentra-
tion 0.5 mg/dL. RDW was measured using the Beckman
Coulter method of counting and sizing, in combination with
an automatic diluting and mixing device for sample process-
ing, and a single beam photometer for hemoglobinometry.
Mathematically, RDW ¼ (standard deviation of red cell
volume/mean cell volume)  100, with higher RDW implying
a greater variety in red cell sizes. Elevated RDWwas defined as
measured RDW  13%.
2.4. Measurement of other confounders and mediators
We defined hypertension as systolic blood pressure greater
than 140 mmHg, diastolic blood pressure greater than
90 mmHg, self-reported diagnosis of hypertension by
a physician, or self-reported use of antihypertensive medica-
tion. Hyperlipidemia was defined as a total blood cholesterol
>200 mg/dL, self-reported diagnosis of hyperlipidemia by
a physician, or self-reported use of cholesterol lowering
medication. Diabetes was defined as a self-reported diagnosis
of diabetes by a physician or use of insulin or oral hypogly-
cemic medication.
Smoking status was determined using serum cotinine
measurements along with the questionnaire items including
“Have you smoked at least 100 cigarettes in your entire life?”
and “Do you now smoke cigarettes?” In the NHANES, serum
cotinine was measured using isotope dilution, high perfor-
mance liquid chromatography/atmospheric pressure chem-
ical ionization tandem mass spectrometry.15 Active smokers
were defined as self-reported active cigarette smoking or
measured serum cotinine 10 ng/mL. All non-active smokers
by self-report were classified as former smokers and never
smokers based on survey question responses.
Glomerular filtration rate (GFR) was estimated using the
modification of diet in renal disease study formula20,21 based
on age, serum creatinine, race and gender. Serum creatinine
was standardized across surveys based on previously pub-
lished calibration equations.22 Chronic kidney disease (CKD)
was defined as an estimated GFR < 60 mL/min/1.73 m2. BMI
was calculated from current height and weight using the
equation BMI ¼ weight (kg)/[height (m)]2.
Since RDW is directly affected by anemia, we adjusted our
analyses for hemoglobin concentration and serum ferritin
concentration. Hemoglobin was measured using standard
hemoglobinometry described above. Ferritinwasmeasured by
using the Bio-Rad Laboratories’ “QuantImune Ferritin IRMA”
kit (Bio-Rad Laboratories, 1986), which is a single-incubation
two-site immunoradiometric assay.15
2.5. Statistical analysis
Statistical analysis was performed using Stata v 12.0 (Stata
Corp., College Station, TX, USA). Data from NHANES
1999e2004 surveys were pooled using standard methods, and
subsequently, 6-year combined weights were calculated.
Survey statistics traditionally used to analyze complex semi-
random survey designs were employed to analyze these
data. Multivariate logistic regression analysis was performedwith low fitness as the outcome measure in the regression
models to obtain adjusted effect estimates and their 95%
confidence intervals (CIs) after accounting for the above-
mentioned confounders. For the purpose of our analysis,
subjects with moderate or high level of fitness were termed as
“controls.” All statistical tests were two-tailed and a p-value
<0.05 was deemed significant.3. Results
Data from 8324 individuals representative of 84 million US
residents was available for analysis. Table 1 demonstrates the
baseline characteristics of the study population. The preva-
lence (SE) of low cardiorespiratory fitness was estimated as
21.2 (0.9)%. The population with low-level fitness was signifi-
cantly younger in comparison to the control population
( p < 0.001). There was a higher prevalence of lower cardio-
respiratory fitness among females as compared to males
( p < 0.001). Subjects with lower cardiorespiratory fitness were
more likely to be black or Mexican-American than white. As
evident in Table 2, there were no significant differences in the
prevalence of hypertension, hyperlipidemia, diabetes, CKD or
active smoking between the two study groups. However, the
mean BMI in the low-fitness group was significantly higher in
comparison to the control group ( p < 0.001). Thirty percent of
Table 3 e Proportion of subjects with high CRP (‡0.5 mg/
dL) between the study groups.
Low fitness
(n ¼ 2394)
Controls
(n ¼ 5930)
p-Value
Whole cohort 17.4 (1.1) 12.4 (0.6) <0.001
Males 10.5 (1.3) 8.3 (0.7) 0.09
Females 24.1 (2.1) 17.2 (1.0) 0.004
Race
Whites 16.2 (2.9) 12.0 (1.3) 0.3
Blacks 22.2 (1.9) 13.0 (1.9) <0.001
Mexican-Americans 20.5 (1.7) 15.7 (1.9) 0.002
Others 14.0 (2.2) 11.5 (2.2) 0.9
Co-morbidities
Hypertension 34.9 (3.0) 21.4 (1.6) 0.003
Hyperlipidemia 27.8 (5.1) 19.0 (1.8) 0.6
BMI categories
<25 kg/m2 6.4 (1.4) 6.5 (0.6) 0.9
25e30 kg/m2 12.6 (2.4) 12.1 (1.0) 0.8
30 kg/m2 37.0 (2.3) 29.3 (1.6) 0.004
Chronic Kidney
Disease (GFR < 60 mL/
min/1.73 m2)
14.9 (3.2) 19.0 (2.5) 0.3
Smoking status
Never-smoker 23.6 (2.9) 14.1 (1.1) 0.002
Former-smoker 34.2 (1.8) 12.4 (2.5) 0.003
Active-smoker 21.6 (2.4) 14.6 (1.4) 0.03
0 1 3 4 52
Odds Ratio (95% Cl)
Odds Ratio 
RDW categories 
CRP categories (mg/dL)
RDW <13
RDW 13-16
RDW >=16
Reference
Reference
1.50 (1.12, 2.02)
3.99 (1.85, 8.58)
1.20 (0.84, 1.70)
1.94 (1.23, 3.05)
CRP <0.5
CRP 0.5 -1.0
CRP >=1.0
Fig. 1 e Adjusted odds ratios for low cardiorespiratory
fitness stratified by CRP (upper panel) or RDW categories
(lower panel). The adjusted estimates were derived from
multivariate logistic regression analysis after adjusting for
age, gender, race, hypertension, diabetes, body mass
index, hyperlipidemia, glomerular filtration rate, serum
hemoglobin and serum ferritin concentration. The lowest
category namely CRP< 0.5 mg/dL and RDW< 13% served
as reference categories for respective comparisons.
Table 4 e Proportion of subjects with high RDW (‡13%)
between the study groups.
Low fitness
(n ¼ 2394)
Controls
(n ¼ 5930)
p-Value
Whole cohort 20.4 (1.0) 14.0 (0.6) <0.001
Males 13.4 (1.4) 12.2 (0.8) 0.4
Females 26.9 (1.6) 16.2 (1.1) <0.001
Race
Whites 15.2 (1.0) 10.9 (1.3) 0.03
Blacks 35.8 (1.6) 32.4 (1.8) 0.01
Mexican-Americans 18.5 (1.5) 16.5 (1.8) 0.9
Others 28.8 (7.2) 15.3 (5.3) 0.1
Co-morbidities
Hypertension 34.2 (3.0) 16.8 (2.6) 0.02
Hyperlipidemia 14.8 (3.1) 15.8 (2.8) 0.7
BMI categories
<25 kg/m2 15.1 (1.6) 12.3 (0.7) 0.1
25e30 kg/m2 12.6 (2.4) 12.1 (1.0) 0.002
30 kg/m2 37.0 (2.3) 29.3 (1.6) 0.04
Chronic Kidney Disease
(GFR < 60 mL/
min/1.73 m2)
23.5 (5.3) 16.7 (3.4) 0.4
Smoking status
Never-smoker 21.7 (2.9) 14.0 (1.0) 0.006
Former-smoker 37.2 (1.8) 11.3 (2.5) <0.001
Active-smoker 21.5 (2.4) 15.1 (1.2) 0.03
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compared to only 18.8% of subjects with moderate-high level
fitness ( p < 0.001).
3.1. CRP and cardiorespiratory fitness
Table 3 demonstrates the proportion of patients with elevated
CRP (0.5 mg/dL) stratified by various demographic and clin-
ical characteristics. The prevalence (SE) of elevated CRP was
17.4 (1.1)% in the low-fitness group as compared to 12.4 (0.6)%
in the control population ( p < 0.001). Interestingly, the prev-
alence of elevated CRP was significantly higher among
females in comparison tomales ( p< 0.001 for both low-fitness
and control groups). A significantly higher prevalence of
elevatedCRP in the low-fitness populationwas encountered in
several strata including blacks, Mexican-Americans, hyper-
tensive subjects and obese subjects with BMI  30 kg/m2.
Using multivariate logistic regression analysis, we observed
that subjects with elevated CRP had significantly higher odds
of low cardiorespiratory fitness in comparison to those with
normal CRP. Fig. 1 demonstrates a doseeresponse relation-
ship between increasing CRP and the prevalence of low
cardiorespiratory fitness. We observed that subjects with
CRP  1.0 mg/dL had a 94% (95% CI: 23%e205%) higher odds of
low cardiorespiratory fitness in comparison to those with
serum CRP concentration <0.5 mg/dL.
3.2. RDW and cardiorespiratory fitness
Table 4 demonstrates the proportion of subjects with elevated
RDW (13%) stratified by various clinical and demographic
characteristics. The prevalence (SE) of elevated RDW was20.4 (1.0)% in the low-fitness group as compared to 14.0 (0.6)%
in the control population ( p < 0.001). Similar to the CRP
comparison, we observed that females had a significantly
higher prevalence of elevated RDW than males ( p < 0.001 for
both low-fitness and control groups). A significantly higher
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Fig. 3 e Bar graph demonstrating the prevalence of low
cardiorespiratory fitness among sub-groups constructed
using RDW and CRP categories. For each category, the
prevalence is expressed as percentage (standard error).
Unadjusted Estimates
Normal CRP, Normal RDW 
Odds Ratio (95% Cl) 
Reference
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encountered in several strata including whites, blacks,
hypertensive subjects as well as overweight (BMI 25e30 kg/
m2) and obese subjects (BMI  30 kg/m2).
Using multivariate logistic regression analysis, we demon-
strated that subjects with elevated RDW had significantly
higher odds for low cardiorespiratory fitness than subjects
with normal RDW. Subjects with RDW of 13e16% had 1.5
times (95% CI: 1.1e2.0) higher odds of low cardiorespiratory
fitness as compared to subjects with RDW < 13%. Simi-
larly, subjects with RDW  16% had 4.0 times (95% CI:
1.9e8.6) higher odds of low cardiorespiratory fitness as
compared to subjects with RDW < 13%.
3.3. Interplay of RDW and CRP
Fig. 2 demonstrates the relationship between RDW and CRP
after adjusting for demographic and clinical characteristics.
The figure clearly demonstrates a significant increase in the
proportion of patients with elevated RDW in the two highest
deciles of serum CRP concentrations (CRP > 0.3 mg/dL). Using
multivariate logistic regression analysis, we studied the con-
founding effect of CRP upon the relationship between low
cardiorespiratory fitness and elevated RDW. After adjusting
for the effects of elevated CRP, a significant independent
association between low cardiorespiratory fitness and
elevated RDWwas observed [OR (95% CI): 1.4 (1.1e1.7)]. In this
adjusted multivariate model, the independent association
between CRP (as a continuous variable) and low cardiorespi-
ratory fitness was also statistically significant [OR (95% CI): 1.2
(1.02e1.4)].
Fig. 3 demonstrates the prevalence of low cardiorespiratory
fitness among groups constructed using CRP and RDW cate-
gories. The prevalence (SE) of low cardiorespiratory fitness
among subjects with normal CRP and normal RDW was esti-
mated as 19.2 (0.9)%. The prevalence of low cardiorespiratory0 0.2 0.6 0.8 10.00.4
Median CRP for each decile (mg/dL)
0
0.5
1O
dd
s 
Ra
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Fig. 2 e Relationship between RDW and CRP after adjusting
for clinical and demographic characteristics. The entire
spectrum of CRP values was divided into ten equal deciles
and the median of each decile is represented on the X-axis.
The Y-axis represents the odds ratio of an elevated RDW
(‡ 13%) in each respective CRP decile, using the first decile
(CRP: 0.01 mg/dL) as reference.fitness among subjects with high CRP with normal RDW and
subjects with high CRP with normal RDW was estimated as
24.5 (2.4)% and 25.9 (1.9)% respectively. Although both these
values were significantly higher than the reference group
(normal CRP, normal RDW) ( p < 0.01 for both comparisons),
there was no significant difference in the prevalence of low
cardiorespiratory fitness between these groups ( p ¼ 0.3). The
prevalence of low cardiorespiratory fitness among subjects
with high CRP and high RDW was estimated as 35.8 (3.1)%,
which was significantly higher than all other CRP and RDW
categories ( p < 0.001 for all comparisons).Normal CRP, Normal RDW 
Adjusted Estimates
High CRP, Normal RDW 
High CRP, Normal RDW 
High RDW, Normal CRP  
High RDW, Normal CRP  
High CRP, High RDW
High CRP, High RDW
Odds Ratio 
0 1 2 3 4
Reference
1.18 (0.84, 1.65)
1.35 (1.10, 1.65)
1.55 (1.01, 2.38)
1.37 (1.04, 1.80)
1.47 (1.22, 1.77)
2.35 (1.64, 3.37)
Fig. 4 e Unadjusted (upper panel) and adjusted (lower
panel) odds ratios for low cardiorespiratory fitness among
sub-groups constructed using RDW and CRP categories.
The adjusted estimates were derived from multivariate
logistic regression analysis after adjusting for age, gender,
race, hypertension, diabetes, body mass index,
hyperlipidemia, glomerular filtration rate, serum
hemoglobin and serum ferritin concentration. Subjects
with normal CRP and normal RDW served as the reference
category for this comparison.
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cardiorespiratory fitness derived from multivariate logistic
regression analysis after adjusting for demographic, clinical
and laboratory parameters including serum hemoglobin and
serum ferritin concentration. In comparison to subjects with
normal CRP and normal RDW, a significantly higher adjusted
odds of low cardiorespiratory fitness was observed among
subjects with high RDW with normal CRP [OR (95% CI): 1.4
(1.1e1.7)] and subjects with high RDWwith high CRP [OR (95%
CI): 1.6 (1.01e2.4)].4. Discussion
This study aimed to elucidate the relationship between low
cardiorespiratory fitness with elevated RDW and/or elevated
CRP. In this large dataset representative of the general US
population, we observed a significant association between
elevated RDW (>13%) with low cardiorespiratory fitness. In
addition, we demonstrated a significantly higher prevalence
of low cardiorespiratory fitness among subjects with elevated
CRP. Both these associations demonstrated a doseeresponse
relationship with increasing prevalence of low cardiorespira-
tory fitnesswith higher CRP or higher RDWvalues. In addition,
we observed that subjects with elevated RDW and elevated
CRP had much higher odds of low cardiorespiratory fitness,
in comparison to those with elevation of only CRP or RDW.
Furthermore, gender-based differences were evident in our
study between the studied associations. Females with a low
cardiorespiratory fitness had significantly higher prevalence
of elevated CRP and elevated RDW, in comparison to the cor-
responding male cohort.
The association between elevated RDW and cardiovascular
morbidity was first reported in symptomatic chronic heart
failure patients.23 Subsequently, multiple studies elucidating
the association between elevated RDW in several other
cardiovascular settings including stable coronary artery
disease and acute coronary syndromes.11e13 Several studies
have demonstrated that association of RDW with all-cause
mortality may be independent of anemia status, especially
in the decompensated heart failure settings.10,24e26 This may
indicate that elevation of RDWmay precede the development
of anemia in patients with chronic heart failure.
RDW is a numerical measure of the variability in the size of
circulating red blood cells. High RDW, referred to as anisocy-
tosis, reflects a greater heterogeneity in the erythrocyte size,
which is caused by disturbances in erythrocyte maturation
and degradation.12,27 Although the exact pathophysiologic
mechanisms explaining the association between elevated
RDW and adverse cardiovascular outcomes are not well
understood, several studies have proposed that elevated RDW
may reflect an underlying pro-inflammatory state,13 which
has been shown to be associated with adverse outcomes.28 It
has been demonstrated that a chronic inflammatory state
may contribute to ineffective erythropoiesis causing imma-
ture erythrocytes to enter the circulation, resulting in elevated
RDW. Several mechanisms are believed to mediate the
relationship between the chronic inflammatory state and
ineffective erythropoiesis leading to elevated RDW. Inflam-
matorymarkers like tumor necrosis factor-a and interleukin-6may hinder erythropoiesis via direct suppression of erythroid
precursors, promotion of apoptosis of precursor cells,
enhancement of erythropoietin resistance in the precursor
cell lines and reduction in bioavailability of iron for hemo-
globin synthesis.29,30 In addition to the chronic inflammation,
higher oxidative stress may be another potential mechanism
linking elevated RDW and adverse cardiovascular outcomes.
Higher oxidative stress may lead to reduced erythrocyte
survival and thus may result in anisocytosis due to an
increase in the proportion of circulating premature erythro-
cytes. The association of elevated RDW with higher oxidative
stress and chronic subclinical inflammation hints toward
a close association with adverse cardiovascular outcomes
since both of these underlying pathobiological processes
have been shown to predict outcomes in cardiovascular
disease.6,7,12
Over the past few decades, cardiorespiratory fitness has
emerged as one of the strongest predictors of morbidity and
mortality arising as a result of cardiovascular disease in
subjects with or without heart disease at baseline. Several
studies have demonstrated a dose-dependent inverse rela-
tionship between cardiovascular mortality and cardiorespi-
ratory fitness.2e5 Differences in cardiorespiratory fitness have
been demonstrated to be associated with considerable
changes in the lifetime risks for cardiovascular-related
mortality at each index age.3 For example, a 65-year-old
individual with a low cardiorespiratory fitness level would be
predicted to have a 35.6% risk of lifetime cardiovascular-
related mortality versus a 17.1% risk of death due to heart
disease if he/she had a moderate or high level of fitness. Berry
et al have demonstrated that a single measurement of low
physical fitness in the midlife translates into a 15e20% abso-
lute increase in the lifetime risk of cardiovascular-related
mortality.3 In addition, not only is cardiorespiratory fitness
a predictor for cardiovascular-related morbidity and
mortality, but also fitness represents an established treatment
target which may help improve multiple clinically relevant
risk reduction metrics.
Although several studies have elucidated the role of RDW
and inflammation upon adverse clinical outcomes in estab-
lished heart disease, the temporal relationship of these
biomarkers with cardiovascular disease is not well under-
stood. By demonstrating an association of RDW and CRP
with low cardiorespiratory fitness, our study helps establish
several facts. First, the abnormalities in RDW and CRP that
have seemed to be associated with adverse cardiovascular
outcomes may precede the onset of heart disease by several
decades. Our study demonstrates that young subjects devoid
of physical limitations or cardiopulmonary ailments with
a low exercise capacity are likely to possess a chronic
inflammatory milieu and a high oxidative stress, which may
predispose these individuals to cardiovascular disease in later
life. Secondly, our study helps establish the link between the
strong association between low cardiorespiratory fitness and
an adverse cardiovascular outcome in later life that has been
demonstrated in several studies including the Lipid Research
Clinics,4 Veterans Affairs Study31 and Cooper Center Longi-
tudinal Study.3 We have demonstrated that subjects with
low cardiorespiratory fitness have elevated RDW by virtue of
chronic inflammation and high oxidative stress, which is
i n d i a n h e a r t j o u r n a l 6 4 ( 2 0 1 2 ) 3 8 0e3 8 7386likely to promote atherosclerosis and lead to cardiovascular
disease. Furthermore, we have demonstrated that presence of
elevated RDW along with elevated CRP has a higher likelihood
of being associated with low cardiorespiratory fitness than
elevated CRP or elevated RDW alone.
4.1. Strengths and limitations
Our study is a cross-sectional study and suffers from tradi-
tional biases of this study design. Although it is difficult to
establish, our study helps clarify that elevation of RDW and
CRP precedes the development of cardiovascular disease by
several decades. The results of this study certainly lead to
strong, albeit indirect conclusions, which help further our
understanding about the roles of inflammation and oxidative
stress in the genesis of cardiovascular disease.We derived our
data from a large well-validated and heterogeneous dataset,
which is representative of the general US population. The
cardiorespiratory fitness testingwas performed using a robust
well-validated protocol, thereby, reducing the biases arising
from inaccurate testing.5. Conclusions
In this large representative dataset of the non-
institutionalized general US population, we observed a signif-
icant association between elevated RDW and elevated CRP
with low cardiorespiratory fitness. Both these associations
demonstrated a doseeresponse relationship with increasing
prevalence of low cardiorespiratory fitness with higher CRP or
higher RDW values. In addition, we observed that subjects
with elevated RDWand elevated CRP hadmuch higher odds of
low cardiorespiratory fitness, in comparison to those with
elevation of only CRP or RDW. Furthermore, females with
a low cardiorespiratory fitness had a significantly higher
prevalence of elevated CRP and elevated RDW, in comparison
to the corresponding male cohort.Conflicts of interest
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